Bowhead Specialty Holdings Inc. (NYSE:BOW) Given Consensus Recommendation of “Moderate Buy” by Analysts

Bowhead Specialty Holdings Inc. (NYSE:BOW) has received a consensus rating of “Moderate Buy” from the six research firms that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $37.50.

Several brokerages have recently issued reports on BOW. JPMorgan Chase & Co. boosted their price objective on shares of Bowhead Specialty from $30.00 to $35.00 and gave the company a “neutral” rating in a research note on Tuesday, April 8th. Piper Sandler assumed coverage on Bowhead Specialty in a report on Wednesday, April 16th. They issued an “overweight” rating and a $44.00 price objective on the stock. Keefe, Bruyette & Woods boosted their target price on Bowhead Specialty from $43.00 to $45.00 and gave the stock an “outperform” rating in a report on Friday. Finally, JMP Securities boosted their price objective on shares of Bowhead Specialty from $38.00 to $40.00 and gave the stock a “market outperform” rating in a research note on Friday, April 11th.

Insider Activity at Bowhead Specialty

In other news, Director Ava Schnidman purchased 1,493 shares of the stock in a transaction dated Friday, February 28th. The stock was acquired at an average cost of $33.41 per share, for a total transaction of $49,881.13. Following the acquisition, the director now owns 1,893 shares of the company’s stock, valued at $63,245.13. The trade was a 373.25 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link.

Institutional Trading of Bowhead Specialty

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Barclays PLC bought a new position in shares of Bowhead Specialty during the third quarter worth about $479,000. JPMorgan Chase & Co. bought a new position in Bowhead Specialty in the 3rd quarter worth about $1,382,000. SG Americas Securities LLC bought a new position in Bowhead Specialty in the 4th quarter worth about $344,000. Rhumbline Advisers raised its holdings in shares of Bowhead Specialty by 89.5% during the fourth quarter. Rhumbline Advisers now owns 12,601 shares of the company’s stock valued at $448,000 after buying an additional 5,953 shares during the last quarter. Finally, Peregrine Capital Management LLC boosted its position in Bowhead Specialty by 143.3% during the 4th quarter. Peregrine Capital Management LLC now owns 295,723 shares of the company’s stock worth $10,504,000 after acquiring an additional 174,172 shares during the period.

Bowhead Specialty Stock Performance

Shares of NYSE BOW opened at $39.62 on Friday. The firm has a market cap of $1.29 billion and a P/E ratio of 30.24. Bowhead Specialty has a 1 year low of $22.14 and a 1 year high of $42.29. The firm’s 50 day moving average price is $38.71 and its 200 day moving average price is $35.25.

Bowhead Specialty (NYSE:BOW) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.33 by $0.01. The business had revenue of $174.85 million during the quarter, compared to analysts’ expectations of $105.17 million. As a group, equities analysts predict that Bowhead Specialty will post 1.36 EPS for the current year.

Bowhead Specialty Company Profile

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.